SCHEMBL23595265

SCHEMBL23595265

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4cccc(-c5cccc(-n6c7ccccc7c7c8oc9ccccc9c8ccc76)c5)c4)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.35
MAPT P10636 6/20 0.33
KDM4E B2RXH2 4/20 0.33
LMNA P02545 4/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 5/20 0.33
POLB P06746 3/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
HPGD P15428 1/20 0.33
BRCA1 P38398 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21365797 1.00 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL23595263 0.99 TSHR (0.34) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL21365798 0.99 TSHR (0.34) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL23595298 0.99 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL25133222 0.98 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL21365801 0.97 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL21365793 0.97 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL25133004 0.97 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL25133690 0.97 TSHR (0.35) TSHRMAPTKDM4ELMNAHSD17B10
SCHEMBL18540436 0.97 TSHR (0.36) TSHRMAPTKDM4ELMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2023-03-30 US disclosed
WO-2021132733-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230099759-A1 POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND SLCO4C1, SLCO1A2, PORCN TSHR 4732/4885MAPT 961/4885KDM4E 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.